// App-Quantinova.ai

: Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Researchers

Presenter

  • Alma R. Oskarsdottir

Principal Investigators

  • Brynja R. Gudmundsdottir

  • Pall T. Onundarson

Medical Centers

  • Hematology Laboratory, Landspitali University Hospital, Reykjavik, Iceland

Locations

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved